MPI-485520

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameMPI-485520
Drug Alias NameMPI-485520MPI-0485520
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInhibitor of NF-kappa-B kinase (IKK) inhibitorsSerine/threonine-protein kinase TBK1 inhibitors
TargetsSerine/threonine-protein kinase TBK1Inhibitor of NF-kappa-B kinase (IKK)
Therapy Area/IndicationsInflammationObesityDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMyrexis Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMyrexis Inc
Active IndicationsN/A
Inactive IndicationsInflammationObesityDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A